An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial

AIMS: To estimate the cost-effectiveness of 10 mg rosuvastatin daily for older patients with systolic heart failure in the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) trial. METHODS AND RESULTS: This within trial analysis of CORONA used major cardiovascular (CV) events as t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorgelly, Paula K., Briggs, Andrew H., Wedel, Hans, Dunselman, Peter, Hjalmarson, Åke, Kjekshus, John, Waagstein, Finn, Wikstrand, John, Jánosi, András, van Veldhuisen, Dirk J., Barrios, Vivencio, Fonseca, Cândida, McMurray, John J.V.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Statins
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796144/
https://www.ncbi.nlm.nih.gov/pubmed/20023047
http://dx.doi.org/10.1093/eurjhf/hfp172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796144/
https://www.ncbi.nlm.nih.gov/pubmed/20023047
http://dx.doi.org/10.1093/eurjhf/hfp172

Ejemplares similares